SHP2 Inhibitor Protects AChRs From Effects of Myasthenia Gravis MuSK Antibody
Neurology: Neuroimmunology and NeuroInflammation - United States
doi 10.1212/nxi.0000000000000645
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 12, 2019
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)